溶性瓜尼利基环酶,NO受体,通过其转尼化活性调节内皮依赖的血管放松
bioRxiv : the preprint server for biology
|November 18, 2024
概括
溶性瓜尼利基循环酶 (GC1) 蛋白质的修饰对于血压调节至关重要. 一种特定的突变损害了S-化,导致心血管问题恶化和血管松变化.
科学领域:
- 生物化学 生物化学
- 心血管生理学心血管生理学
- 分子生物学分子生物学
背景情况:
- 可溶性甘基环酶 (GC1) 介导氧化 (NO) 信号传输.
- GC1可以转化其他蛋白质,这个过程涉及氧化甲素1 (oTrx1).
- 在GC1α子单元上的氨酸610 (C610) 是S-尼托罗斯醇 (SNO) 形成的关键部位.
研究的目的:
- 为了研究GC1转化的生理相关性.
- 确定GC1-依赖的S-化在心血管功能和氧化应激中的作用.
- 在GC1突变模型中阐明改变血管松的机制.
主要方法:
- 产生和研究一个敲入鼠标模型,用C610替换为氨酸 (KI αC610S).
- 评估心血管参数 (平均动脉压,心脏功能) 在基底和血管素II (Ang II) 治疗条件下.
- 使用压力肌图和静脉内显微镜分析血管度.
- 全球S-化水平和特定的SNO蛋白质 (SNO-Trx1,SNO-RhoA) 的测量.
主要成果:
- 与野生型 (WT) 小鼠相比,接受Ang II治疗的KI小鼠表现出加剧的高血压和心脏功能障碍.
- KI小鼠显示全球S-化和SNO-Trx1和SNO-RhoA的水平显著降低.
- C610S突变影响了乙胆诱导的血管松,但没有NO刺激的平滑肌肉松.
- 确定GC1-依赖的S-化是内皮衍生的高极化至关重要的.
结论:
- 依赖GC1的S-化对于维持正常的血压和心血管健康至关重要.
- 在C610S突变脱离NO信号通路,影响内皮依赖的血管松.
- 在规范的NO-cGMP通路之外,GC1转化活性在调节血管度方面发挥着重要作用.
相关概念视频
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Antihypertensive Drugs: Vasodilators
479
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
479
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
GTPases and their Regulation
8.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.3K
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K


